What managed entry agreement (MEA)/ price could be negotiated for our drug/medical device in Belgium?
After Innosens defines the optimal pricing and reimbursement path for your product in Belgium, Innosens will support and guide you during the entire MEA negotiation procedure, from an article 111, 112 or 113 request to obtaining an agreement with the Minister of Budget and the Ministry of Social Affairs. Thanks to a deep knowledge regarding payers’ expectations, Innosens will help you to:
- Identify the uncertainties raised by the CRM on your product
- Prepare an innovative MEA proposition to address these uncertainties
- Prepare the meeting(s) with the working group